These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9171961)

  • 1. Stimulation of gastric osmoreceptors but not the sodium monitor increases renal angiotensin-converting enzyme activity.
    Ye VZ; Duggan KA
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):463-4. PubMed ID: 9171961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the gastric sodium monitor reduces hepatic angiotensin-converting enzyme activity.
    Duggan KA; Ye VZ
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):449-50. PubMed ID: 9171956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors regulating renal angiotensin-converting enzyme activity in the rat.
    Ye VZ; Duggan KA
    Acta Physiol Scand; 2000 May; 169(1):21-7. PubMed ID: 10759607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the intrahepatic renin-angiotensin system after stimulation of the gastric sodium monitor in the rat.
    Ye VZ; Duggan KA
    Clin Sci (Lond); 2000 Jan; 98(1):57-64. PubMed ID: 10600659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal endosomes contain angiotensin peptides, converting enzyme, and AT(1A) receptors.
    Imig JD; Navar GL; Zou LX; O'Reilly KC; Allen PL; Kaysen JH; Hammond TG; Navar LG
    Am J Physiol; 1999 Aug; 277(2):F303-11. PubMed ID: 10444586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme in developing lung and kidney.
    Wallace KB; Bailie MD; Hook JB
    Am J Physiol; 1978 Mar; 234(3):R141-5. PubMed ID: 204202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme (ACE), characterization by 125I-MK351A binding studies of plasma and tissue ACE during variation of salt status in the rat.
    Jackson B; Cubela R; Johnston C
    J Hypertens; 1986 Dec; 4(6):759-65. PubMed ID: 3029219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma renin activity and changes in tissue angiotensin converting enzyme.
    Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL
    J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High salt intake and the brain renin--angiotensin system in Dahl salt-sensitive rats.
    Zhao X; White R; Huang BS; Van Huysse J; Leenen FH
    J Hypertens; 2001 Jan; 19(1):89-98. PubMed ID: 11204309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrarenal Mas and AT
    O'Neill J; Healy V; Johns EJ
    Exp Physiol; 2017 Dec; 102(12):1700-1715. PubMed ID: 28940861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat.
    Ye VZ; Duggan KA
    Clin Sci (Lond); 2000 Sep; 99(3):201-6. PubMed ID: 11787472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
    Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
    Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats.
    Erman A; van Dyk DJ; Chen-Gal B; Giler ID; Rosenfeld JB; Boner G
    Eur J Clin Invest; 1993 Oct; 23(10):615-20. PubMed ID: 8281980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin treatment reduces the increased serum and lung angiotensin converting enzyme activity in streptozotocin-induced diabetic rats.
    Erman A; Chen-Gal B; David I; Giler S; Boner G; van Dijk DJ
    Scand J Clin Lab Invest; 1998 Feb; 58(1):81-7. PubMed ID: 9516660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II: a humoral mediator for the gastric sodium monitor.
    Duggan KA; Ye VZ; Jones DM; Macdonald GJ
    Am J Physiol; 1996 Mar; 270(3 Pt 2):F406-10. PubMed ID: 8780241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of microvascular rarefaction and reduced renal mass hypertension.
    Rieder MJ; Roman RJ; Greene AS
    Hypertension; 1997 Jul; 30(1 Pt 1):120-7. PubMed ID: 9231831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
    Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
    J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the local occurrence of angiotensin II in rat kidney and its modulation by dietary sodium intake and converting enzyme blockade.
    Mendelsohn FA
    Clin Sci (Lond); 1979 Aug; 57(2):173-9. PubMed ID: 477254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.